What Are Flavonoids?

Flavonoids, also known as bioflavonoids, are a diverse group of polyphenolic compounds ubiquitously distributed throughout the plant kingdom. Chemically, they are characterized by a basic diphenylpropane (C6-C3-C6) skeleton, consisting of two aromatic rings (A and B) linked by a three-carbon bridge that typically forms a heterocyclic ring (C).
This structural framework gives rise to thousands of individual compounds, which are generally subdivided into several major classes based on the oxidation state of the central ring:
- Flavonols (e.g., Quercetin, Kaempferol)
- Flavones (e.g., Apigenin, Luteolin)
- Flavanones (e.g., Hesperidin, Naringenin)
- Flavanols (Flavan-3-ols) (e.g., Catechins from green tea)
- Anthocyanidins (responsible for red, blue, and purple pigments)
- Isoflavones (e.g., Genistein, Daidzein).
Molecular Mechanisms of Biological Activity
The therapeutic potential of flavonoids is derived from their multi-target interaction capabilities across several physiological systems.
Antioxidant and Redox Signaling
The primary mechanism of action for most flavonoids is their antioxidant activity, which involves the direct scavenging of ROS and RNS. They neutralize free radicals through single-electron oxidation reactions and stabilize the resulting radicals through electron delocalization across the conjugated double bonds and carbonyl groups. Beyond direct scavenging, flavonoids upregulate endogenous antioxidant enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase. For instance, quercetin enhances cell proliferation and intracellular glutathione (GSH) levels by upregulating glutamate-cysteine ligase (GCLC). [1,2]
Anti-Inflammatory Pathways
Flavonoids modulate inflammatory processes by inhibiting key enzymes such as cyclooxygenase (COX), lipoxygenase, and xanthine oxidase. A central mechanism involves the suppression of the Nuclear Factor-kappa B (NF-κB) signaling pathway. By downregulating the activation of NF-κB and the subsequent expression of pro-inflammatory cytokines like IL-1β, IL-6, and TNF-α, flavonoids such as luteolin and quercetin provide relief from chronic inflammatory conditions like colitis and atherosclerosis. [3]
Anti-Carcinogenic and Anti-Tumorigenic Effects
The anti-cancer potential of flavonoids is multifaceted [4,5], involving:
- Cell Cycle Arrest: Induction of arrest at G0/G1 or G2/M phases through modulation of cyclin-dependent kinases (CDKs).
- Apoptosis Induction: Activation of caspase cascades and modulation of Bcl-2 family proteins.
- Inhibition of Angiogenesis: Targeting vascular endothelial growth factor (VEGF) and its receptors to inhibit tumor blood supply.
- Metastasis Suppression: Reversing epithelial-mesenchymal transition (EMT) and inhibiting matrix metalloproteinases (MMPs).
Specific flavonoids like silibinin and phloretin have shown promising results in treating colorectal cancer (CRC) and castration-resistant prostate cancer (CRPC) by targeting the PI3K/Akt/mTOR and SRC non-receptor tyrosine kinase pathways. [6]
Table of Targeted Molecular Mechanisms
| Mechanism | Target Pathway/Enzyme | Flavonoid Example | Physiological Effect |
| Redox Modulation | Nrf2/HO-1 Signaling | Quercetin | Enhanced cytoprotection and ferroptosis inhibition. |
| Inflammation | NF-κB, COX-2, iNOS | Luteolin, Apigenin | Reduced cytokine storm and tissue damage. |
| Metabolism | PI3K/AKT/mTOR | Silibinin, Hesperetin | Regulation of glucose and tumor cell proliferation. |
| Neuroprotection | Acetylcholinesterase (AChE) | Macluraxanthone, Isoflavones | Increased neural acetylcholine levels for AD. |
| Cardiovascular | miRNA Modulators | Epicatechin, Anthocyanins | Inhibition of cardiac fibrosis and hypertrophy. |
Selection Guide by Flavonoid Subclass
Quick Reference for Common Flavonoid Selection Based on Research Focus
| Flavonoid Subclass | Representative Compounds | Catalog | Typical Research Applications | Price |
|---|
| Flavonols | Quercetin | ACM117395-3 | Antioxidant mechanisms, cardiovascular health, anti-inflammatory pathways | Inquiry |
| Kaempferol | ACM520183-3 | Inquiry |
| Myricetin | ACM529442-2 | Inquiry |
| Flavones | Apigenin | ACM520365-2 | Neuroprotection, anti-cancer screening, anti-inflammatory studies | Inquiry |
| Luteolin | ACM491703-3 | Inquiry |
| Flavanones | Hesperidin | ACM520263-3 | Metabolic disorders, vascular health, lipid metabolism | Inquiry |
| Naringenin | ACM480411-4 | Inquiry |
| Eriodictyol | ACM552589-1 | Inquiry |
| Flavanols (Catechins) | EGCG | ACM989515-5 | Antioxidant activity, metabolic research, neuroprotection | Inquiry |
| EGC | ACM970741-3 | Inquiry |
| ECG | ACM1257085-2 | Inquiry |
| EC | ACM490460-5 | Inquiry |
| Anthocyanidins | Cyanidin | ACM13306053 | Pigment studies, oxidative stress, anti-aging research | Inquiry |
| Delphinidin | ACM528530-3 | Inquiry |
| Malvidin | ACM643845-2 | Inquiry |
| Isoflavones | Genistein | ACM446720-3 | Hormone-related research, bone health, cancer prevention | Inquiry |
| Daidzein | ACM486668-3 | Inquiry |
Choosing Between Aglycones and Glycosides: The Case of Quercetin vs. Rutin
A critical decision in procurement is choosing between the aglycone form (e.g., Quercetin) and its glycosylated counterparts (e.g., Rutin).
- Bioavailability: Intestinal uptake for quercetin glycosides is significantly higher (~52%) compared to the aglycone (~24%) or rutin (~17%). However, rutin is more stable in specific formulations and acts as a slow-release precursor of quercetin.
- Bioactivity: Quercetin aglycone generally displays superior in vitro potency, specifically in the inhibition of Angiotensin-Converting Enzyme (ACE) and Acetylcholinesterase (AChE) compared to rutin.
Related Products
References
- Chen, Shen, et al. Molecules 28.13 (2023): 4982.
- Stachelska, Milena Alicja, et al. Applied Sciences 15.19 (2025): 10840.
- Xu, Zhiyue, et al. Frontiers in Nutrition 12 (2025): 1698231.
- Kumar, Shashank, et al. The scientific world journal 2013.1 (2013): 162750.
- Pandey, Pratibha, et al. Frontiers in pharmacology 15 (2025): 1513422.
- Zhang, PingPing, et al. Frontiers in Pharmacology 16 (2025): 1633286.